United States


ITUS.OQ on NASDAQ Stock Exchange Capital Market

23 Feb 2018
Change (% chg)

$0.03 (+0.90%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Itus Corporation Terminates At-The-Market Offering
Tuesday, 12 Dec 2017 07:00am EST 


Itus enters into 2-year collaboration agreement
Wednesday, 22 Nov 2017 05:23pm EST 

Nov 22 (Reuters) - Itus Corp ::Itus Corp - ‍on Nov 17, co, through unit entered into a 2 -year collaboration agreement with H. Lee Moffitt Cancer Center And Research Institute​.Itus - ‍ deal to advance toward human clinical testing car-t technology licensed by unit from Wistar Institute aimed initially at treating ovarian cancer​.Itus Corp says unit of co to pay Moffitt $1.16 million over two years for its efforts in collaboration - SEC filing.Itus Corp - unit to work with researchers at Moffitt to complete studies necessary to submit an IND application for technology with U.S. FDA​.Itus Corp - ‍first payment from unit to Moffitt to be paid upon execution of agreement, and subsequent installments to be paid periodically thereafter​.  Full Article

ITUS Corp licenses CAR-T technology from Wistar Institute
Tuesday, 14 Nov 2017 07:00am EST 

Nov 14 (Reuters) - ITUS Corp :ITUS Corporation licenses CAR-T technology from the Wistar Institute.Itus Corp - ‍executed exclusive worldwide license agreement with Wistar Institute for a Chimeric Antigen Receptor T-Cell (CAR-T) technology.ITUS Corp - has formed a subsidiary, Certainty Therapeutics Inc, to develop and commercialize innovative CAR-T technology​.  Full Article

ITUS Corp files for stock shelf offering of up to $24 mln
Monday, 16 Oct 2017 06:24am EDT 

Oct 16 (Reuters) - ITUS Corp :ITUS Corp - files for stock shelf offering of up to $24 million - SEC filing‍​.  Full Article

Itus corp - ‍entered at-market issuance sales agreement with fbr capital to create equity program to sell up to $3.7 million common stock​
Friday, 29 Sep 2017 12:12pm EDT 

Sept 29 (Reuters) - Itus Corp ::Entered at-the-market issuance sales agreement with FBR capital to create equity program to sell up to $3.7 million common stock​.  Full Article

Itus Corp and Wistar Institute renew collaborative research agreement
Monday, 7 Aug 2017 09:00am EDT 

Aug 7 (Reuters) - Itus Corp :The Wistar Institute and Itus Corporation renew collaborative research agreement.Itus corp - ‍ Itus and Wistar Institute have renewed their collaboration for development of CCHEK, the company's early cancer detection technology​.  Full Article

Itus Corp appoints Dr. Amit kumar as new CEO
Friday, 7 Jul 2017 09:02am EDT 

July 7 (Reuters) - Itus Corp :Itus appoints Dr. Amit Kumar as new CEO and announces management changes.Itus Corp says Amit Kumar replaces Robert Berman, who has resigned as president, CEO and as a director.Itus Corp says in addition, Mike Catelani, Itus' CFO, has been promoted to chief operating officer.  Full Article

ITUS Corp prices public offering of up to 3.5 mln shares
Thursday, 11 May 2017 08:22am EDT 

May 11 (Reuters) - Itus Corp :ITUS corporation announces pricing of public offering of up to 3.5 million shares of common stock.ITUS corp - priced aggregate of 3.5 million shares of company's common stock at a price to public of $1.05 per share.  Full Article

ITUS Corp announces proposed public offering of common stock
Wednesday, 10 May 2017 05:16pm EDT 

May 10 (Reuters) - ITUS Corp ::ITUS Corporation announces proposed public offering of common stock.  Full Article

ITUS extends its collaboration with Virtua Healthcare System
Tuesday, 9 May 2017 08:00am EDT 

May 9 (Reuters) - ITUS Corp : :ITUS extends its collaboration with Virtua Healthcare System.Pursuant to extension, Virtua will continue to provide patient samples for ITUS'S ongoing cancer study through may of 2018.  Full Article

BRIEF-Lewis Titterton Reports 6.6 Pct Stake In Itus Corp As Of Feb. 14, 2018

* LEWIS H. TITTERTON REPORTS 6.6 PERCENT STAKE IN ITUS CORP AS OF FEBRUARY 14, 2018 - SEC FILING‍​ Source text (http://bit.ly/2CoeRLH) Further company coverage:

No consensus analysis data available.